IL93163A0 - Anti viral riboside comprising pharmaceutical compositions - Google Patents
Anti viral riboside comprising pharmaceutical compositionsInfo
- Publication number
- IL93163A0 IL93163A0 IL93163A IL9316390A IL93163A0 IL 93163 A0 IL93163 A0 IL 93163A0 IL 93163 A IL93163 A IL 93163A IL 9316390 A IL9316390 A IL 9316390A IL 93163 A0 IL93163 A0 IL 93163A0
- Authority
- IL
- Israel
- Prior art keywords
- riboside
- pharmaceutical compositions
- anti viral
- viral
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/301,454 US5132291A (en) | 1989-01-24 | 1989-01-24 | Antivirals and methods for increasing the antiviral activity of azt |
Publications (1)
Publication Number | Publication Date |
---|---|
IL93163A0 true IL93163A0 (en) | 1990-11-05 |
Family
ID=23163437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL93163A IL93163A0 (en) | 1989-01-24 | 1990-01-24 | Anti viral riboside comprising pharmaceutical compositions |
Country Status (9)
Country | Link |
---|---|
US (1) | US5132291A (fr) |
EP (1) | EP0406408A4 (fr) |
JP (1) | JPH03503538A (fr) |
AU (1) | AU5040790A (fr) |
CA (1) | CA2008445A1 (fr) |
FI (1) | FI904695A0 (fr) |
IE (1) | IE900275L (fr) |
IL (1) | IL93163A0 (fr) |
WO (1) | WO1990008550A1 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776838B1 (en) | 1987-10-28 | 2010-08-17 | Wellstat Therapeutics Corporation | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
US5968914A (en) * | 1987-10-28 | 1999-10-19 | Pro-Neuron, Inc. | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
US5736531A (en) | 1987-10-28 | 1998-04-07 | Pro-Neuron, Inc. | Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides |
IL99125A0 (en) * | 1990-08-10 | 1992-07-15 | Gensia Pharma | Derivatives of imidazole analog of aica riboside and their use |
US5654423A (en) * | 1990-11-21 | 1997-08-05 | Regents Of The University Of California | Boronated metalloporphyrine and therapeutic methods |
CZ285232B6 (cs) * | 1991-05-16 | 1999-06-16 | Glaxo Group Limited | Protivirové směsi |
US20030207813A1 (en) * | 1996-12-09 | 2003-11-06 | G.D. Searle | Retroviral protease inhibitor combinations |
US5872104A (en) * | 1994-12-27 | 1999-02-16 | Oridigm Corporation | Combinations and methods for reducing antimicrobial resistance |
US20030100532A1 (en) | 1997-02-14 | 2003-05-29 | Gary S. Jacob | Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
US6174873B1 (en) | 1998-11-04 | 2001-01-16 | Supergen, Inc. | Oral administration of adenosine analogs |
AU3595500A (en) * | 1999-02-12 | 2000-08-29 | G.D. Searle & Co. | Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
US8642581B1 (en) | 2000-02-11 | 2014-02-04 | Brian D. Halevie-Goldman | Compositions and methods for the production of S-adenosylmethionine within the body |
ES2192495B1 (es) * | 2002-03-21 | 2005-02-16 | Universidad De Barcelona | Nuevo uso terapeutico del ribosido de 5-aminoimidazol-4-carboxamida (acadesina). |
US20040116351A1 (en) * | 2002-12-06 | 2004-06-17 | Fast Balance, Inc. | Method for enhancing the natural reward system for exercise |
JP2008534601A (ja) | 2005-03-28 | 2008-08-28 | ペリコー セラピューティクス, インコーポレイテッド | 患者における副作用を予防または減少するための方法、組成物および処方物 |
US20070082859A1 (en) * | 2005-10-07 | 2007-04-12 | Stover Richard R | Formulations of AICA riboside |
WO2008086341A1 (fr) * | 2007-01-09 | 2008-07-17 | Pericor Therapeutics, Inc. | Procédés, compositions et formulations pour prévenir ou réduire les effets indésirables chez un patient |
EP2276464A2 (fr) * | 2008-04-15 | 2011-01-26 | Mallinckrodt Inc. | Compositions contenant des composés antiviraux et leurs procédés d utilisation |
WO2010040110A1 (fr) * | 2008-10-03 | 2010-04-08 | Pericor Therapeutics, Inc. | Procédés et compositions pour le traitement de l’insuffisance cardiaque aiguë |
EP3600150B1 (fr) | 2017-03-24 | 2023-05-17 | Merit Medical Systems, Inc. | Ensembles vasculaires sous-cutanés pour améliorer la circulation sanguine |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4321366A (en) * | 1978-05-12 | 1982-03-23 | Research Corporation | Process of preparing 2-azido-2-deoxyarabinofuranosyl halides |
US4575498A (en) * | 1983-07-21 | 1986-03-11 | Duke University | Method for restoring depleted purine nucleotide pools |
US4724232A (en) * | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
US4874751A (en) * | 1985-03-16 | 1989-10-17 | Burroughs Wellcome Co. | Antibacterial treatment |
US4847244A (en) * | 1985-09-17 | 1989-07-11 | Burroughs Wellcome Co. | Treatment of human viral infections |
AU5668886A (en) * | 1986-03-27 | 1987-10-20 | Harry Edward Gruber | A method of increasing adenosine excretion |
US4880782A (en) * | 1986-11-21 | 1989-11-14 | Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. | Method of treating viral infections in humans and compositions therefor |
-
1989
- 1989-01-24 US US07/301,454 patent/US5132291A/en not_active Expired - Fee Related
-
1990
- 1990-01-24 IE IE900275A patent/IE900275L/xx unknown
- 1990-01-24 AU AU50407/90A patent/AU5040790A/en not_active Abandoned
- 1990-01-24 EP EP19900902900 patent/EP0406408A4/en not_active Withdrawn
- 1990-01-24 WO PCT/US1990/000362 patent/WO1990008550A1/fr not_active Application Discontinuation
- 1990-01-24 JP JP2503102A patent/JPH03503538A/ja active Pending
- 1990-01-24 IL IL93163A patent/IL93163A0/xx unknown
- 1990-01-24 CA CA002008445A patent/CA2008445A1/fr not_active Abandoned
- 1990-09-24 FI FI904695A patent/FI904695A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU5040790A (en) | 1990-08-24 |
EP0406408A4 (en) | 1992-01-02 |
IE900275L (en) | 1990-07-24 |
EP0406408A1 (fr) | 1991-01-09 |
WO1990008550A1 (fr) | 1990-08-09 |
FI904695A0 (fi) | 1990-09-24 |
JPH03503538A (ja) | 1991-08-08 |
US5132291A (en) | 1992-07-21 |
CA2008445A1 (fr) | 1990-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9025491D0 (en) | Pharmaceutical compositions | |
GR900100868A (en) | Viral agent | |
IL93163A0 (en) | Anti viral riboside comprising pharmaceutical compositions | |
GB2222772B (en) | Pharmaceutical compositions | |
GB2219940B (en) | Pharmaceutical compositions | |
IL93162A0 (en) | Anti hiv pharmaceutical compositions | |
IL94821A0 (en) | Monosaccharide compounds and pharmaceutical compositions containing the same | |
GB9004016D0 (en) | Pharmaceutical compositions | |
GB8909022D0 (en) | Pharmaceutical compositions | |
GB8916072D0 (en) | Pharmaceutical compositions | |
HUT56269A (en) | Pharmaceutical compositions | |
ZA905512B (en) | Pharmaceutical compositions | |
GB8909906D0 (en) | Pharmaceutical compositions | |
GB2217202B (en) | Trimelamol-containing pharmaceutical compositions | |
GB8909880D0 (en) | Pharmaceutical compositions | |
GB8916070D0 (en) | Pharmaceutical compositions | |
GB8914099D0 (en) | Pharmaceutical compositions | |
GB8922129D0 (en) | Pharmaceutical compositions | |
GB8919447D0 (en) | Pharmaceutical compositions | |
IE894216L (en) | Pharmaceutical compositions | |
IE891521L (en) | Pharmaceutical compositions | |
GB8919446D0 (en) | Pharmaceutical compositions | |
GB8919130D0 (en) | Pharmaceutical compositions | |
GB8917287D0 (en) | Pharmaceutical compositions | |
IL89935A0 (en) | Pharmaceutical compositions |